Trial intelligence / Profile preview

Calcitriol in Diabetic Kidney Disease

NCT05298163Unknown

Sponsor
Universitas Indonesia
Start
Apr 2022
Primary completion
Oct 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of calcitriol in diabetic kidney disease (DKD) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: Urinary podocin at 6 months, Urinary nephrin at 6 months and 4 more. Status: unknown.

02

Drugs

calcitriol
03

Conditions

diabetic kidney disease (DKD)

Beyond the preview

Go deeper on NCT05298163.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05298163.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call